Human trials underway for 3-in-1 jab to protect against respiratory illnesses.

The University of the Sunshine Coast will lead trials in Brisbane for an investigational vaccine that could address three respiratory viruses in one.

UniSC Clinical Trials staff will enroll participants in a Moderna phase 1 trial of a combination investigational vaccine for COVID-19, influenza, and respiratory syncytial virus (RSV) at its South Bank clinic in Brisbane.

https://www.usc.edu.au/about/unisc-news/news-archive/2023/january/investigational-respiratory-3-in-one-vaccine-clinical-trial-begins-in-brisbane